GO
Loading...

Pharma industry 'Shakespearean drama'

Monday, 9 Jun 2014 | 7:19 AM ET

Discussing the evolution of big pharmaceutical companies, and Valeant's old and new R&D model, with Michael Porter, Harvard Business School professor. Bill Ackman, founder and CEO of Pershing Square Capital Management, weighs in.